Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Net Income (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Net Income for 12 consecutive years, with -$25.5 million as the latest value for Q1 2026.

  • For Q1 2026, Net Income fell 28.17% year-over-year to -$25.5 million; the TTM value through Mar 2026 reached -$142.4 million, down 222.22%, while the annual FY2025 figure was -$130.3 million, 68.27% down from the prior year.
  • Net Income hit -$25.5 million in Q1 2026 for Cartesian Therapeutics, up from -$77.4 million in the prior quarter.
  • Across five years, Net Income topped out at $15.0 million in Q2 2024 and bottomed at -$196.7 million in Q4 2023.
  • Average Net Income over 5 years is -$24.6 million, with a median of -$17.9 million recorded in 2023.
  • Year-over-year, Net Income soared 5505.67% in 2022 and then tumbled 3437.15% in 2023.
  • Cartesian Therapeutics' Net Income stood at $5.9 million in 2022, then crashed by 3437.15% to -$196.7 million in 2023, then soared by 87.66% to -$24.3 million in 2024, then plummeted by 218.7% to -$77.4 million in 2025, then surged by 67.08% to -$25.5 million in 2026.
  • According to Business Quant data, Net Income over the past three periods came in at -$25.5 million, -$77.4 million, and -$19.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.